IRIS
DANIELI, Maria Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.427
EU - Europa 2.227
AS - Asia 801
SA - Sud America 204
AF - Africa 77
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.342
IT - Italia 455
UA - Ucraina 374
SG - Singapore 274
RU - Federazione Russa 255
IE - Irlanda 237
DE - Germania 214
SE - Svezia 211
BR - Brasile 190
CN - Cina 161
HK - Hong Kong 160
DK - Danimarca 137
GB - Regno Unito 113
FI - Finlandia 85
TR - Turchia 81
CA - Canada 73
KR - Corea 72
FR - Francia 67
MA - Marocco 37
CI - Costa d'Avorio 33
NL - Olanda 32
IN - India 22
BE - Belgio 15
AT - Austria 10
AR - Argentina 9
MX - Messico 8
PK - Pakistan 5
PL - Polonia 5
AU - Australia 4
ID - Indonesia 4
RS - Serbia 4
TW - Taiwan 4
BD - Bangladesh 3
EU - Europa 3
IQ - Iraq 3
JO - Giordania 3
CH - Svizzera 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
PE - Perù 2
RO - Romania 2
UG - Uganda 2
ZA - Sudafrica 2
AL - Albania 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 6.743
Salva come PNG Salva come JPEG
Città #
Jacksonville 389
Chandler 388
Fairfield 257
Dublin 231
Ashburn 230
Boardman 227
Hong Kong 158
Wilmington 147
Woodbridge 144
Singapore 133
New York 116
Ann Arbor 97
Seattle 97
Houston 93
Lawrence 87
Princeton 87
Des Moines 82
San Mateo 82
Moscow 70
Cambridge 66
The Dalles 64
Montréal 62
Centro 59
Mcallen 49
Munich 48
San Diego 41
Abidjan 33
Turin 28
Washington 23
Beijing 22
Milan 22
Los Angeles 21
Helsinki 20
Pune 17
Redmond 16
Brussels 14
Shanghai 14
São Paulo 14
Ancona 13
Wuhan 13
Saint Petersburg 12
Castelfidardo 11
Guangzhou 10
Norwalk 10
Dallas 9
London 9
Nuremberg 9
Chiaravalle 8
Kilburn 8
Palermo 7
Massafra 6
Mexico City 6
Rio de Janeiro 6
Rome 6
Recife 5
Rotella 5
Vienna 5
Alghero 4
Amsterdam 4
Auburn Hills 4
Belgrade 4
Bergamo 4
Brescia 4
Chiswick 4
Falls Church 4
Florence 4
Genoa 4
Iesi 4
Jiaxing 4
Joinville 4
Mascalucia 4
Montemarciano 4
Naples 4
Ottawa 4
Porto 4
Porto Alegre 4
Sirolo 4
Tolentino 4
Vallefoglia 4
Warsaw 4
Aarhus 3
Amman 3
Baghdad 3
Belo Horizonte 3
Blumenau 3
Boston 3
Buenos Aires 3
Campo Grande 3
Catania 3
Charlotte 3
Curitiba 3
Fano 3
Fayetteville 3
Frankfurt am Main 3
Groningen 3
Lecce 3
Montreal 3
Monza 3
Osasco 3
Palm Beach Gardens 3
Totale 4.058
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 305
Colonna vertebrale. Midollo spinale. Imaging 157
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 140
La scelta della maternità. Una guida alla decisione per le donne con LES 121
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 116
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 111
Cardiac involvement in polymyositis and dermatomyositis 105
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 102
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 101
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 97
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 97
7th International Immunoglobulin Conference: Immunomodulation. 96
Subcutaneous IgG in the Myositis Spectrum Disorders 95
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 89
Overexpression of the cytokine BAFF and autoimmunity risk 89
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 88
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 87
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 87
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 86
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 86
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 84
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 82
6th International Immunoglobulin Symposium: poster presentations. 81
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 81
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 81
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 77
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 77
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 76
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 76
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 76
Bullous SLE: response to methotrexate and relationship with disease activity 76
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 76
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 75
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 73
Dr. Guerra, et al reply 73
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 73
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 72
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 72
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 72
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 71
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 70
Risk factors for Sjögren's syndrome: a case-control study. 70
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 70
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 69
La terapia immunosoppressiva nelle miositi refratttarie 68
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 68
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 68
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 68
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 66
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 64
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 63
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 62
The European Society for Immunodeficiencies (ESID) registry 2014 62
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 61
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 61
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. 59
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 58
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 58
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 57
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 57
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 57
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 57
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 56
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 56
Subcutaneous immunoglobulins in ocular myositis. 56
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 56
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 56
Preliminary report on the use of subcutaneous immunoglobulin in severe inflammatory myopathies 56
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 56
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 55
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 55
Ultrasonographic contrast-enhanced study of sicca syndrome 55
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 53
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 53
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 52
Lessons from the "Euro-Lupus Cohort". 50
Splenic microcalcifications in systemic lupus erythematosus 49
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 49
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 49
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 48
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 46
Immunoglobulin Treatment inPolymyositis and Dermatomyositis 44
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 44
Alarmins in autoimmune diseases 42
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 42
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 42
Subcutaneous immunoglobulin G in idiopathic inflammatory myopathies: therapeutic implications. 41
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 40
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 40
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 40
Valutazione obbiettiva strutturata della competenza clinica (osce) 38
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. 35
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 34
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 32
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies 31
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 27
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency 25
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 23
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis 19
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 19
Totale 6.836
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020142 0 0 0 0 0 0 0 0 0 0 36 106
2020/20211.137 66 114 141 5 154 58 131 60 120 87 134 67
2021/2022674 29 176 15 34 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024921 160 40 56 126 144 188 18 34 10 32 19 94
2024/20251.440 135 171 76 31 66 94 181 91 329 160 106 0
Totale 6.904